Mesa Laboratories Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.7% | +10.6% | +2.7% | +7.2% | +14.1% | +13.8% | +37.6% | +18.8% | -1.3% | +11.5% | +3.4% | |
| – | +19.0% | +21.6% | +2.8% | +1.6% | +23.9% | -10.3% | +60.4% | +13.5% | -2.9% | +8.6% | +0.8% | |
| – | +18.5% | +3.6% | +2.6% | +11.5% | +7.3% | +33.1% | +25.4% | +22.6% | -0.3% | +13.2% | +4.9% | |
| – | +20.6% | +4.7% | -14.9% | -0.9% | +81.3% | +63.5% | +51.8% | +30.0% | -5.8% | +1.1% | +4.0% | |
| – | +38.5% | -3.4% | +15.1% | +19.2% | +22.0% | +19.9% | +31.7% | +20.1% | +0.6% | +0.6% | +7.3% | |
| – | +27.5% | +5.2% | +4.6% | +11.5% | +33.4% | +30.0% | +39.8% | +24.9% | +210.9% | -66.8% | +3.9% | |
| – | +2.9% | -0.1% | -86.6% | +348.1% | -19.0% | +56.0% | -62.0% | -29.4% | -8,295.0% | – | +13.3% | |
| – | – | – | – | -100.0% | – | +45.8% | -51.6% | +22.8% | +19.4% | +108.2% | -9.8% | |
| – | +1.4% | -8.1% | -97.9% | +2,764.8% | -55.2% | -40.4% | +55.2% | -110.9% | – | – | +101.5% | |
| – | -23.9% | -29.0% | +4.8% | -65.1% | +83.0% | -146.6% | – | -177.5% | – | – | -33.2% | |
| – | +16.6% | +0.1% | -126.5% | – | -76.2% | +84.1% | -42.9% | -50.3% | -27,438.3% | – | – | |
| – | +9.2% | +6.6% | -61.0% | +261.8% | -36.8% | +25.2% | +16.2% | +15.3% | -735.4% | – | -16.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.